Nasal peripheral T-cell lymphoma: A 20-year review of cases treated in Scotland

S. Senan, R. P. Symonds, I. L. Brown

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

The nasal peripheral (post-thymic) T-cell lymphoma is an important cause of the midline granuloma syndrome (MGS), in which ulceration and destruction of the tissues of the nose and paranasal sinuses occurs. We reviewed the histology of 9 cases of the MGS treated with radiotherapy, and, using immunocytochemistry, showed 8 cases to be peripheral T-cell lymphomas (PTCL) and 1 a B-cell lymphoma. All patients received radiotherapy and 2 died shortly after treatment from unrelated causes. Two patients with T-cell lymphoma and the solitary case of B-cell lymphoma achieved long-term disease-free survival. The 4 remaining cases of T-cell lymphoma relapsed locally at a median interval of 3.5 months despite megavoltage irradiation of 45-50 Gy (in 3 cases) and inclusion of uninvolved paranasal sinuses and the nasopharynx in the field (in 2 cases). All patients with local relapse achieved, and remain in, remission after treatment with alkylating agents and prednisolone. The disappointing response of some cases of nasal T-cell lymphoma to radiotherapy has been reported by others, and this may be due partly to the heterogeneity of nasal lymphomas. We are unable to provide clear guidelines for treatment but suggest that a role exists for initial treatment with oral alkylating agents and steroids in newly diagnosed cases.

Original languageEnglish
Pages (from-to)96-100
Number of pages5
JournalClinical Oncology
Volume4
Issue number2
DOIs
Publication statusPublished - 1 Jan 1992

Cite this

Senan, S. ; Symonds, R. P. ; Brown, I. L. / Nasal peripheral T-cell lymphoma : A 20-year review of cases treated in Scotland. In: Clinical Oncology. 1992 ; Vol. 4, No. 2. pp. 96-100.
@article{45ceb02846ee416f8e02982cde840bff,
title = "Nasal peripheral T-cell lymphoma: A 20-year review of cases treated in Scotland",
abstract = "The nasal peripheral (post-thymic) T-cell lymphoma is an important cause of the midline granuloma syndrome (MGS), in which ulceration and destruction of the tissues of the nose and paranasal sinuses occurs. We reviewed the histology of 9 cases of the MGS treated with radiotherapy, and, using immunocytochemistry, showed 8 cases to be peripheral T-cell lymphomas (PTCL) and 1 a B-cell lymphoma. All patients received radiotherapy and 2 died shortly after treatment from unrelated causes. Two patients with T-cell lymphoma and the solitary case of B-cell lymphoma achieved long-term disease-free survival. The 4 remaining cases of T-cell lymphoma relapsed locally at a median interval of 3.5 months despite megavoltage irradiation of 45-50 Gy (in 3 cases) and inclusion of uninvolved paranasal sinuses and the nasopharynx in the field (in 2 cases). All patients with local relapse achieved, and remain in, remission after treatment with alkylating agents and prednisolone. The disappointing response of some cases of nasal T-cell lymphoma to radiotherapy has been reported by others, and this may be due partly to the heterogeneity of nasal lymphomas. We are unable to provide clear guidelines for treatment but suggest that a role exists for initial treatment with oral alkylating agents and steroids in newly diagnosed cases.",
keywords = "Chemotherapy, Diagnosis, Nasal T-cell lymphoma, Radiotherapy",
author = "S. Senan and Symonds, {R. P.} and Brown, {I. L.}",
year = "1992",
month = "1",
day = "1",
doi = "10.1016/S0936-6555(05)80974-4",
language = "English",
volume = "4",
pages = "96--100",
journal = "Clinical Oncology",
issn = "0936-6555",
publisher = "W.B. Saunders Ltd",
number = "2",

}

Nasal peripheral T-cell lymphoma : A 20-year review of cases treated in Scotland. / Senan, S.; Symonds, R. P.; Brown, I. L.

In: Clinical Oncology, Vol. 4, No. 2, 01.01.1992, p. 96-100.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Nasal peripheral T-cell lymphoma

T2 - A 20-year review of cases treated in Scotland

AU - Senan, S.

AU - Symonds, R. P.

AU - Brown, I. L.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - The nasal peripheral (post-thymic) T-cell lymphoma is an important cause of the midline granuloma syndrome (MGS), in which ulceration and destruction of the tissues of the nose and paranasal sinuses occurs. We reviewed the histology of 9 cases of the MGS treated with radiotherapy, and, using immunocytochemistry, showed 8 cases to be peripheral T-cell lymphomas (PTCL) and 1 a B-cell lymphoma. All patients received radiotherapy and 2 died shortly after treatment from unrelated causes. Two patients with T-cell lymphoma and the solitary case of B-cell lymphoma achieved long-term disease-free survival. The 4 remaining cases of T-cell lymphoma relapsed locally at a median interval of 3.5 months despite megavoltage irradiation of 45-50 Gy (in 3 cases) and inclusion of uninvolved paranasal sinuses and the nasopharynx in the field (in 2 cases). All patients with local relapse achieved, and remain in, remission after treatment with alkylating agents and prednisolone. The disappointing response of some cases of nasal T-cell lymphoma to radiotherapy has been reported by others, and this may be due partly to the heterogeneity of nasal lymphomas. We are unable to provide clear guidelines for treatment but suggest that a role exists for initial treatment with oral alkylating agents and steroids in newly diagnosed cases.

AB - The nasal peripheral (post-thymic) T-cell lymphoma is an important cause of the midline granuloma syndrome (MGS), in which ulceration and destruction of the tissues of the nose and paranasal sinuses occurs. We reviewed the histology of 9 cases of the MGS treated with radiotherapy, and, using immunocytochemistry, showed 8 cases to be peripheral T-cell lymphomas (PTCL) and 1 a B-cell lymphoma. All patients received radiotherapy and 2 died shortly after treatment from unrelated causes. Two patients with T-cell lymphoma and the solitary case of B-cell lymphoma achieved long-term disease-free survival. The 4 remaining cases of T-cell lymphoma relapsed locally at a median interval of 3.5 months despite megavoltage irradiation of 45-50 Gy (in 3 cases) and inclusion of uninvolved paranasal sinuses and the nasopharynx in the field (in 2 cases). All patients with local relapse achieved, and remain in, remission after treatment with alkylating agents and prednisolone. The disappointing response of some cases of nasal T-cell lymphoma to radiotherapy has been reported by others, and this may be due partly to the heterogeneity of nasal lymphomas. We are unable to provide clear guidelines for treatment but suggest that a role exists for initial treatment with oral alkylating agents and steroids in newly diagnosed cases.

KW - Chemotherapy

KW - Diagnosis

KW - Nasal T-cell lymphoma

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0026831215&partnerID=8YFLogxK

U2 - 10.1016/S0936-6555(05)80974-4

DO - 10.1016/S0936-6555(05)80974-4

M3 - Review article

VL - 4

SP - 96

EP - 100

JO - Clinical Oncology

JF - Clinical Oncology

SN - 0936-6555

IS - 2

ER -